Renal Amyloidosis

How to Cite This Chapter: Miller M, Hruby Z, Drabczyk R. Renal Amyloidosis. McMaster Textbook of Internal Medicine. Kraków: Medycyna Praktyczna. Accessed January 18, 2021.
Last Updated: July 16, 2017
Last Reviewed: July 3, 2019
Chapter Information

Renal amyloidosis is a glomerulopathy resulting from glomerular deposition of insoluble fibrillar proteins in the mesangium of the glomerulus.

Definition, classification, epidemiology, clinical presentation, diagnosis, and treatment of amyloidosis: see Amyloidosis.

Diagnosis is confirmed by the presence of amyloid protein on immunofluorescence and electron microscopy. Many different types of amyloid protein exist, but the two most common subtypes are AL and AA amyloid:

1) AL amyloidosis is the most common renal amyloidosis. It results in organized deposits of light chains in the glomerulus. Renal involvement occurs in approximately 50% of patients and manifests as decreased renal function and proteinuria. Nephrotic syndrome can occur. Hypertension is usually absent and the kidneys are often enlarged. Renal treatment response is related to the degree of improvement in light chain production from the underlying condition. Proteinuria and renal function improve with successful therapy.

2) AA amyloidosis is a secondary amyloidosis. It develops as a response to chronic inflammatory conditions such as rheumatoid arthritis. In contrast to AL amyloidosis, renal involvement is almost universal and presents with varying levels of proteinuria. Treatment of the underlying condition may lead to reduction of proteinuria, stabilization of renal function, and in some cases even to a reduction in the amount of amyloid deposited in the kidneys.

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.